Midatech appoints new chairman and chief medical officer

UK nanotechnology firm Midatech, focused on the design, synthesis and manufacture of nanomedicines based on its gold-nanoparticle (GNP) technology, has announced the appointments of Rolf Stahel as chairman and Craig Cook as Chief Operating Officer (COO) and Chief Medical Officer (CMO).

Mr Stahel (pictured) has more than 40 years of experience in the pharmaceutical industry, of which 20 years were spent at CEO and Board level in public and private life science companies across Europe, the US and India.

He was Chief Executive Officer at Shire between 1994 and 2003, during which time he led the company’s listing on the London Stock Exchange in 1996 and development into a global specialty biopharmaceutical company. He joined Shire from Wellcome (now GSK) where he spent 27 years in positions of increasing seniority.